Red White & Bloom Brands Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RWBYF research report →
Price Chart
About the company
Red White & Bloom Brands Inc. operates within the cannabis industry, focusing on both the cultivation and retail sale of its various products. The company's primary market presence is concentrated in the U.
- CEO
- Brad Rogers
- IPO
- 2021
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on RWBYF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $13.71M
- P/E
- -0.15
- PEG
- 0.00
- P/S
- 0.24
- P/B
- -0.06
- EV/EBITDA
- -28.76
- Div Yield
- 0.00%
- Gross Margin
- 20.65%
- Op Margin
- -32.52%
- Net Margin
- -150.71%
- ROE
- 43.38%
- ROIC
- -9.29%
Latest fiscal year · YoY change
- Revenue
- $88.33M+0.7%
- Gross Profit
- $29.48M+30.1%
- Op Income
- $-8,274,000
- Net Income
- $-138,898,000+43.4%
- EPS
- $-0.28+55.6%
- OCF Growth
- +50.5%
- FCF Growth
- +50.0%
- 52W High
- $0.14
- 52W Low
- $0.00
- 50D MA
- $0.04
- 200D MA
- $0.05
- Beta
- 0.55
- RSI (14)
- 45
- Avg Volume
- 15.44K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Red White & Bloom reported sharply higher Q3 revenue and EBITDA, while management emphasized Michigan regulatory progress and upcoming vertical-integration gains in Florida and Michigan.· November 30, 2021
- Q3 revenue was $11.8 million, up 93% year over year from $6.1 million.
- Q3 EBITDA was $5.9 million versus an EBITDA loss of $5.8 million a year ago; net loss improved to $5.5 million from $9.5 million.
- Nine-month revenue reached $36.9 million, up 386%, and gross profit excluding fair value items rose to $21.5 million.
- Management said reported revenue is understated in Michigan due to legacy contracts, with Q3 adjusted sales of $32.2 million and nine-month adjusted sales of $99.2 million.
- The company expects first product sales from Florida facilities in Q1 2022 and says Michigan/Illinois regulatory steps remain pending.
Q3 2021 revenue was $11.8 million, compared with $6.1 million in Q3 2020, an increase of 93%. Q3 EBITDA was $5.9 million versus an EBITDA loss of $5.8 million in Q3 2020; net loss was $5.5 million versus $9.5 million. For the nine months ended September 30, 2021, revenue was $36.9 million, up 386% from $7.6 million, and gross profit excluding fair value items was $21.5 million, up 295% from $5.5 million. Nine-month net loss was $73.8 million versus $29.8 million a year ago. Management also said Q3 IFRS revenue was $11.8 million versus adjusted sales of $32.2 million, and nine-month IFRS revenue was $36.9 million versus adjusted sales of $99.2 million. Forward-looking, the company expects first product sales from its Florida facilities in Q1 2022, first harvest from Apopka pods in Q4, and revenue realization from those assets in Q1 2022. Management also said it is working toward Michigan license approvals and aims to move forward with Illinois in the first half of 2022.
Brad Rogers framed the quarter as evidence that the company is building a foundation for premium brands and vertical integration across core states. He repeatedly stressed that Michigan’s reported revenue is understated because of legacy licensing structures and said the company is progressing on regulatory approvals that would allow it to recognize more of the business. His tone was upbeat and promotional, but he also acknowledged delays, quiet-period restrictions, and that some transactions have taken longer than hoped.
Chris Ecken highlighted the Q3 and nine-month numbers, including $11.8 million in Q3 revenue, $5.9 million in Q3 EBITDA, and the improvement in Q3 net loss to $5.5 million. He also pointed to nine-month gross profit excluding fair value items of $21.5 million and explained that SG&A rose from $22 million to $60 million, driven by depreciation, amortization of licenses, and staffing as the company scales. On capital structure, he said the company may refinance shorter-term debt into longer-term debt at lower rates and could consider divesting non-core assets to reduce liabilities.
Analysts and investors focused on Michigan, Illinois, rising liabilities, and how the company intends to become profitable. Management said Michigan consists of two major pieces: bringing the existing Platinum Vape business under a structure that allows full top-line recognition, and closing the investee acquisition once final regulatory approvals are secured; Brad also said the company is doing about 400,000 vapes per month from the PV line, excluding other brands. On Illinois, Brad said the issue is the complexity of acquiring a nonprofit license holder and that the company is working with regulators to structure the deal for the first half of 2022. In response to leverage concerns, Chris said the company may refinance short-term debt and potentially sell non-core assets, and to profitability he pointed to brand strength in Michigan, cost-out from the new processing facility, and Florida’s higher gross-margin profile.
The company delivered strong top-line growth and positive EBITDA in Q3, while management said reported revenue could rise materially once Michigan and Florida are fully reflected. Brad and Chris both suggested the operating base is being built for better margins, with vertical integration, brand expansion, and higher-margin Florida operations expected to improve profitability in 2022. Management also said Platinum Vape is the number one cartridge brand in Michigan and is expanding into more product categories.
A large portion of the company’s growth is still constrained by regulatory approvals and legacy contract structures, especially in Michigan and Illinois. SG&A rose sharply to $60 million over nine months, and net loss widened to $73.8 million, reflecting heavy buildout costs and non-cash items. Management also acknowledged higher liabilities from short-term acquisition debt and said some transactions have taken longer than expected.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 88.0%
- Shares Outstanding
- 491.39M
- Float Shares
- 432.30M
of shares held by institutions
1 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Formulafolio Investments, LLC | 93 | 0 |
Our RWBYF coverage
Recent articles, reports, and earnings notes.
No research on RWBYF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RWBYF report →Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Completes Acquisition of Ayurcann's Health Canada-Licensed Manufacturing Operations, Leading Vape & Pre-Roll Brands, and Expanded National Distribution Capabilities
globenewswire.com · Jun 8
Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group
globenewswire.com · Jun 3
Red White & Bloom Brands' Subsidiary, Emblem Cannabis, Selected as Successful Bidder to Acquire Health Canada-Licensed Manufacturing Operations, Leading Vape & Pre-Roll Brands, and Expanded National Distribution Capabilities
globenewswire.com · Apr 13
Red White & Bloom Brands Announces Appointment of Michael Di Brina as New Director
globenewswire.com · Jan 13
Red White & Bloom Brands Closes Debt Settlement
globenewswire.com · Dec 9
Red White & Bloom Brands Files 2025-Q3 Interim Financial Statements
globenewswire.com · Dec 1
CSE Bulletin: Reinstatement - Red White & Bloom Brands Inc. (RWB)
newsfilecorp.com · Oct 3
Red White & Bloom Files 2025 Interim Financial Statements
globenewswire.com · Oct 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.